Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
PRISM BioLab raises 1.5 billion yen in Series C fundraising to advance technologies and programs targeting protein-protein interactions 2024-01-24 16:00
Onward Therapeutics Announces Enrollment of Phase 1 Clinical Trial of a Novel Bispecific Antibody (OT-A201) Targeting Two Immune Checkpoints 2024-01-24 15:00
Harbour BioMed Announces IND Clearance for HBM9027 in the U.S. 2024-01-24 12:40
WuXi XDC and Celltrion Sign MOU for Integrated Services for Antibody-Drug Conjugates (ADCs) 2024-01-24 11:37
PharmAbcine Announces First Patient Dosed in Phase 1a/b Clinical Trial of PMC-309 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced or Metastatic Solid Tumors 2024-01-24 10:01
Sciwind Biosciences Announces Positive Results from Phase 1 Clinical Trial of XW004, an Oral Formulation of Long-acting GLP-1 Analog Ecnoglutide 2024-01-24 10:00
INTREPID Alliance Releases Review of Antiviral Compounds in Clinical Development to Contribute to Collaborative Efforts in Pandemic Preparedness 2024-01-24 08:22
Akeso Presented Promising Results of Cadonilimab and Lenvatinib in Combination with TACE in uHCC at 2024 ASCO GI 2024-01-23 21:00
FDA Grants Breakthrough Device Designation to Amadix´s preventive screening blood test for Colorectal Cancer 2024-01-23 18:00
Gannex's Strategic Partner Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH 2024-01-23 12:17
European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma's Treatment for Sanfilippo Syndrome (Type A) 2024-01-23 11:53
First Myeloma Patient Treated with CAR-T Successfully Discharged 2024-01-23 10:19
NK CellTech Announces FDA Clearance for Clinical Trial of NK010 2024-01-22 20:10
Telix Highlights Presentations at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2024) 2024-01-22 19:00
Everest Medicines Announces 2023 Revenue Expected to be Between RMB124 Million and RMB126 Million 2024-01-22 07:50
Sanyou Super Trillion Peptide Molecule Discovery Platform Officially Launched Today 2024-01-20 08:00
CARsgen's Presents Updated Research Results on CT041 at 2024 ASCO GI Meeting 2024-01-19 21:50
Top Employer 2024 certification reflects Boehringer Ingelheim Vietnam's impactful people development 2024-01-19 19:28
Call for Application for 2024 Tsinghua Amgen Scholars Program 2024-01-19 15:32
Harbour BioMed Announces Positive Profit Alert 2024-01-19 12:52
1 56 57 58 59 60 451